Nano Form.
Nano Formulation & Characterisation
Operated by Research Unit 06
Institutional Narrative & Focus
The Nano Formulation & Characterisation Unit addresses the frontiers of drug delivery and nanotechnology, helping partners formulate, optimize, and characterize nanostructured materials. From lipid nanoparticles (LNPs) and liposomes to polymeric nanoparticles and nano-emulsions, we provide robust analytical workflows to assess stability, morphology, and release kinetics. The unit specializes in Dynamic Light Scattering (DLS) and Nanoparticle Tracking Analysis (NTA) for direct size distribution and zeta potential measurements. In addition, we design custom encapsulation studies to optimize the loading and release profiles of sensitive biomolecules, ensuring their therapeutic efficiency.
Scope of Services
Our specific testing configurations, validated chemical assays, and molecular panels:
- Particle size distribution & zeta potential (DLS)
- Nanoparticle Tracking Analysis (NTA) for liposomes & EVs
- Nanoparticle Size & Morphology Analysis (TEM/SEM)
- Drug loading and encapsulation efficiency determination
- In vitro release profiling of nano-formulations
- Accelerated stability testing of colloidal dispersions
- Functional Group Characterisation (FTIR Spectroscopy)
- Crystallinity & Structural Analysis (XRD)
- Spectroscopic Characterisation of Drug–Carrier Interaction (UV–Vis/FTIR)
- DSC/TGA
Start a Project
Enquire About This Service
Send details of your testing protocol, sample batch sizes, or collaboration proposal.